Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway

References

• Van der Meulen J, Van Roy N, Van Vlierberghe P, et al. The epigenetic landscape of T-cell acute lymphoblastic leukemia. Int J Biochem Cell Biol. 2014;53:547–557.
   PubMed Web of Science ®Google Scholar
• Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2017;56(2):89–116.
   PubMed Web of Science ®Google Scholar
• Kaveri D, Kastner P, Dembele D, et al. β-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood. 2013;122(5):694–704.
   PubMed Web of Science ®Google Scholar
• Huang ZF, Wang TY, Fu MW, et al. [Treatment and prognosis of adult T cell acute lymphoblastic leukemia]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41(4):485–491.
   PubMedGoogle Scholar
• Brown PA, Shah B, Fathi A, et al. NCCN guidelines insights: acute lymphoblastic leukemia, version 1.2017. J Natl Compr Canc Netw. 2017;15(9):1091–1102.
   PubMed Web of Science ®Google Scholar
• Follini E, Marchesini M, Roti G. Strategies to overcome resistance mechanisms in T-Cell acute lymphoblastic leukemia. IJMS. 2019;20(12):3021.
   Google Scholar
• Fielding AK, Richards SM, Chopra R, et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood. 2007;109(3):944–950.
   PubMed Web of Science ®Google Scholar
• Ng OH, Erbilgin Y, Firtina S, et al. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia. Blood Cancer J. 2014;4(3):e192.
   PubMedGoogle Scholar
• Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461–1473.
   PubMed Web of Science ®Google Scholar
• Garcia DHA, Dunach M. Intracellular signals activated by canonical wnt ligands independent of GSK3 inhibition and beta-Catenin stabilization. Cells-Basel. 2019;8(10):1148.
   PubMed Web of Science ®Google Scholar
• Ding X, Zhang B, Pei Q, et al. Triptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1. BMC Cancer. 2014;14:271.
   PubMed Web of Science ®Google Scholar
• Jiang W, Chen M, Xiao C, et al. Triptolide suppresses growth of breast cancer by targeting HMGB1 in vitro and in vivo. Biol Pharm Bull. 2019;42(6):892–899.
   PubMed Web of Science ®Google Scholar
• Zhao H, Shi P, Deng M, et al. Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption. Oncotarget. 2016;7(51):85515–85528.
   PubMedGoogle Scholar
• Wang X, Ma LM, Wang T, et al. [Effect of low-dose triptolide and sorafenib alone and their combination on AML cell line MV411 and the pathway of STAT5]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27(4):1088–1093.
   PubMedGoogle Scholar
• Xu CB, Liao B, Shen JZ, et al. [Effects of triptolide on the apoptosis and H3K4 protein methylation in multiple myeloma cells]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2017;33(5):450–455.
   PubMedGoogle Scholar
• Shih YL, Hsieh CB, Lai HC, et al. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway. Int J Cancer. 2007;121(5):1028–1035.
   PubMed Web of Science ®Google Scholar
• Griffiths EA, Gore SD, Hooker C, et al. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation. Leuk Lymphoma. 2010;51(9):1711–1719.
   PubMed Web of Science ®Google Scholar
• Jia Y, Yang Y, Liu S, et al. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma. Epigenetics-Us. 2010;5(8):743–749.
   PubMed Web of Science ®Google Scholar
• Zhu J, Wang Y, Duan J, et al. DNA methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer. J Exp Clin Cancer Res. 2012;31(1):80.
   PubMedGoogle Scholar
• Chen J, Zheng W, Jiang X, et al. Triptolide induces apoptosis of human acute T lymphocytic leukemia Jurkat cells via inhibiting transcription of human endogenous retrovirus HERV-K Np9 gene. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35(5):702–706.
   PubMedGoogle Scholar
• Li M, Zhang X, Zhou WJ, et al. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance. Acta Pharmacol Sin. 2013;34(12):1545–1553.
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhou K, Cheng L, et al. MBD2 ablation impairs lymphopoiesis and impedes progression and maintenance of T-ALL. Cancer Res. 2018;78(7):1632–1642.
   PubMed Web of Science ®Google Scholar
• Bonnet M, Loosveld M, Montpellier B, et al. Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia. Blood. 2011;117(24):6650–6659.
   PubMed Web of Science ®Google Scholar
• Su HY, Lai HC, Lin YW, et al. Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through wnt signaling pathway. Int J Cancer. 2010;127(3):555–567.
   PubMed Web of Science ®Google Scholar
• Malinauskas T, Jones EY. Extracellular modulators of Wnt signalling. Curr Opin Struct Biol. 2014;29:77–84.
   PubMed Web of Science ®Google Scholar
• Valencia A, Roman-Gomez J, Cervera J, et al. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia. Leukemia. 2009;23(9):1658–1666.
   PubMed Web of Science ®Google Scholar
• Botezatu A, Iancu IV, Plesa A, et al. Methylation of tumour suppressor genes associated with thyroid cancer. CBM. 2019;25(1):53–65.
   Google Scholar
• Tang M, Torres-Lanzas J, Lopez-Rios F, et al., Wnt signaling promoter hypermethylation distinguishes lung primary adenocarcinomas from colorectal metastasis to the lung. 2006;119(11):2603–2606.
   Google Scholar
• Dvorska D, Brany D, Nagy B, et al. Aberrant methylation status of tumour suppressor genes in ovarian cancer tissue and paired plasma samples. IJMS. 2019;20(17):4119.
   Google Scholar
• Zhang W, Glockner SC, Guo M, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-Box containing gene 17 in colorectal cancer. Cancer Res. 2008;68(8):2764–2772.
   PubMed Web of Science ®Google Scholar
• Fu D, Ren C, Tan H, et al. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer. Medicine (Baltimore). 2015;94(11):e637.
   PubMed Web of Science ®Google Scholar
• Oliveira LH, Schiavinato JL, Fraguas MS, et al. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia. Cancer Sci. 2015;106(10):1264–1277.
   PubMed Web of Science ®Google Scholar